Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP50560.RAXRAbZCgydO0vmg58BiN_A91pTQ1T7Hf4MxpL6ymHXJw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP50560.RAXRAbZCgydO0vmg58BiN_A91pTQ1T7Hf4MxpL6ymHXJw130_assertion type Assertion NP50560.RAXRAbZCgydO0vmg58BiN_A91pTQ1T7Hf4MxpL6ymHXJw130_head.
- NP50560.RAXRAbZCgydO0vmg58BiN_A91pTQ1T7Hf4MxpL6ymHXJw130_assertion description "[We used the allelic discrimination method to identify polymorphisms in GSTT1, SULT1C2, CDA, SXR (drug metabolic pathways), XPD, XPA, XPG, ERCC1, TOP2A (DNA repair), VEGF (angiogenesis), and MDR1 (multidrug resistance) genes in 110 adult patients with intermediate-risk AML, enrolled in the CETLAM-99 prospective trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP50560.RAXRAbZCgydO0vmg58BiN_A91pTQ1T7Hf4MxpL6ymHXJw130_provenance.
- NP50560.RAXRAbZCgydO0vmg58BiN_A91pTQ1T7Hf4MxpL6ymHXJw130_assertion evidence source_evidence_literature NP50560.RAXRAbZCgydO0vmg58BiN_A91pTQ1T7Hf4MxpL6ymHXJw130_provenance.
- NP50560.RAXRAbZCgydO0vmg58BiN_A91pTQ1T7Hf4MxpL6ymHXJw130_assertion SIO_000772 16507781 NP50560.RAXRAbZCgydO0vmg58BiN_A91pTQ1T7Hf4MxpL6ymHXJw130_provenance.
- NP50560.RAXRAbZCgydO0vmg58BiN_A91pTQ1T7Hf4MxpL6ymHXJw130_assertion wasDerivedFrom gad-20150221 NP50560.RAXRAbZCgydO0vmg58BiN_A91pTQ1T7Hf4MxpL6ymHXJw130_provenance.
- NP50560.RAXRAbZCgydO0vmg58BiN_A91pTQ1T7Hf4MxpL6ymHXJw130_assertion wasGeneratedBy ECO_0000203 NP50560.RAXRAbZCgydO0vmg58BiN_A91pTQ1T7Hf4MxpL6ymHXJw130_provenance.